Atlas Trials

Memantine Hydrochloride in Prostate Cancer Patients

Clinical trial NCT07164794 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07164794
Sponsor
Bin Xu
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Castration-resistant Prostate Cancer (mCRPC)Prostate CancerNeuroendocrine Prostate Cancer (NEPC)
Start date
2025-11-01
Primary completion
2028-06-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.